天津医药 ›› 2020, Vol. 48 ›› Issue (6): 499-503.

• 新冠专题 • 上一篇    下一篇

T淋巴细胞亚群在新型冠状病毒肺炎诊疗中的临床意义

林敏青 1,夏文广 2,徐波 3,徐爱平 4,王夜明 4△

  

  1. 1湖北中医药大学第一临床学院(邮编430061);2湖北省中西医结合医院康复医学中心,3呼吸与危重症医学科,
  • 收稿日期:2020-02-24 修回日期:2020-03-26 出版日期:2020-06-15 发布日期:2020-06-15
  • 通讯作者: 林敏青 E-mail:528143680@qq.com

Clinical Significance of T-Lymphocyte Subsets in the Treatment of COVID-19

LIN Min-qing1, XIA Wen-guang2, XU Bo3, XU Ai-ping4, WANG Ye-ming4△ #br#   

  1. 1 The First Clinical College, Hubei University of Chinese Medicine, Wuhan 430061, China; 2 Department of Rehabilitation
    Medicine, 3 Department of Pulmonary and Critical Care Medicine, 4 Department of Intensive Care Unit, Hubei Provincial
    Hospital of Integrated Chinese and Western Medicine

  • Received:2020-02-24 Revised:2020-03-26 Published:2020-06-15 Online:2020-06-15
  • Contact: Min-Qing LIN E-mail:528143680@qq.com

摘要: 摘要:新型冠状病毒(SARS-CoV-2)以其强传染力通过呼吸道飞沫或密切接触广泛传播。新型冠状病毒肺炎 (COVID-19)患者以发热和(或)咳嗽为首发症状,部分患者迅速进展为重症,严重威胁患者生命。免疫紊乱是 COVID-19 重症化发展的重要因素,本文通过总结 COVID-19 与 T 淋巴细胞亚群的关系,阐述 T 淋巴细胞亚群对 COVID-19病情监测、治疗指导的临床意义,建议病程中动态监测T淋巴细胞亚群水平,预判病情并积极干预,以期为 临床防治免疫炎症级联反应、逆转重症进展提供指导

关键词: 新型冠状病毒肺炎, 新型冠状病毒, 免疫, T淋巴细胞亚群, CD4+ T淋巴细胞, CD8+ T淋巴细胞

Abstract: Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is widely spread due to its strong infectivity by close contact via droplets or skin touch. With fever or cough as the first symptom, some patients suffering from coronavirus disease 2019 (COVID-19) quickly progressed to serious condition, which severely threatened the health of patients. As immunodeficiency is a significant factor of the poor condition, the relationship between COVID-19 and T-lymphocyte subsets will be summarized. The paper is written to indicate the clinical significance of T-lymphocyte subsets in the monitoring and treatment of COVID-19. It is suggested that the subgroup levels of T-lymphocyte subsets should be dynamically monitored during the course of disease for better understanding the condition and taking positive intervention, which will provide guidance to control immune inflammatory cascade and hold back the development of critical situation.

Key words: coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, immunity, T-lymphocyte subsets, CD4+ T-lymphocytes, CD8+ T-lymphocytes